EVNIN LUKE — SEC insider filings

SEC reporting owner CIK 1134657. 79 insider filings on record with FilingPulse; latest filed 2026-09-09.

Transaction summary — filings shown

Covers the 50 most recent of 79 filings on record, filed 2021-11-30 to 2026-09-09. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Aktis Oncology, Inc. (AKTS)10% owner11 leg · 1,112,777 sh · $20,029,986—6
iTeos Therapeutics, Inc. (ITOS)—5—26 legs · 933,271 sh · $16,695,328—
Entrada Therapeutics, Inc. (TRDA)10% owner5—14 legs · 540,669 sh · $4,517,581—
Werewolf Therapeutics, Inc. (HOWL)Director36—88 legs · 4,312,285 sh · $3,258,1057
TCR2 THERAPEUTICS INC. (TCRR)10% owner2—1 leg · 70,170 sh · $131,9204
Oncorus, Inc. (ONCR)Director1——1

Insider filings — EVNIN LUKE

FiledFormIssuerReported transactionsSource
2026-09-094Entrada Therapeutics, Inc. (TRDA)
jointly with MPM BioVentures 2014, L.P., GADICKE ANSBERT, Foley Todd, MPM BioVentures 2014 (B), L.P., MPM Asset Management Investors BV2014 LLC, MPM BioVentures 2014 LLC, MPM BioVentures 2014 GP LLC, MPM BIOVENTURES 2018 (B), L.P., MPM ASSET MANAGEMENT INVESTORS BV2018 LLC
Sale (S): 38,500 @ $7.11 · Sale (S): 192,500 @ $7.41 · Sale (S): 28,837 @ $7.13EDGAR
2026-09-034Entrada Therapeutics, Inc. (TRDA)
jointly with MPM BioVentures 2014, L.P., GADICKE ANSBERT, Foley Todd, MPM BioVentures 2014 (B), L.P., MPM Asset Management Investors BV2014 LLC, MPM BioVentures 2014 LLC, MPM BioVentures 2014 GP LLC, MPM BIOVENTURES 2018 (B), L.P., MPM ASSET MANAGEMENT INVESTORS BV2018 LLC
Sale (S): 29,088 @ $7.06 · Sale (S): 25,131 @ $7.19 · Sale (S): 32,263 @ $7.17EDGAR
2026-08-314Entrada Therapeutics, Inc. (TRDA)
jointly with MPM BioVentures 2014, L.P., GADICKE ANSBERT, Foley Todd, MPM BioVentures 2014 (B), L.P., MPM Asset Management Investors BV2014 LLC, MPM BioVentures 2014 LLC, MPM BioVentures 2014 GP LLC, MPM BIOVENTURES 2018 (B), L.P., MPM ASSET MANAGEMENT INVESTORS BV2018 LLC
Sale (S): 38,922 @ $7.20 · Sale (S): 3,733 @ $7.01 · Sale (S): 44,259 @ $6.99EDGAR
2026-08-264Entrada Therapeutics, Inc. (TRDA)
jointly with MPM BioVentures 2014, L.P., GADICKE ANSBERT, Foley Todd, MPM BioVentures 2014 (B), L.P., MPM Asset Management Investors BV2014 LLC, MPM BioVentures 2014 LLC, MPM BioVentures 2014 GP LLC, MPM BIOVENTURES 2018 (B), L.P., MPM ASSET MANAGEMENT INVESTORS BV2018 LLC
Sale (S): 21,623 @ $7.34 · Sale (S): 26,522 @ $7.54 · Sale (S): 14,569 @ $7.06EDGAR
2026-07-084Werewolf Therapeutics, Inc. (HOWL)Sale (S): 35,770 @ $0.32 · Sale (S): 107,429 @ $0.31EDGAR
2026-06-294Werewolf Therapeutics, Inc. (HOWL)Sale (S): 157,084 @ $0.30EDGAR
2026-06-104Werewolf Therapeutics, Inc. (HOWL)Sale (S): 76,928 @ $0.37EDGAR
2026-06-084Werewolf Therapeutics, Inc. (HOWL)Sale (S): 20,072 @ $0.44 · Sale (S): 24,946 @ $0.40 · Sale (S): 60,547 @ $0.40EDGAR
2026-06-034Werewolf Therapeutics, Inc. (HOWL)Sale (S): 80,459 @ $0.47 · Sale (S): 29,595 @ $0.45 · Sale (S): 29,749 @ $0.42EDGAR
2026-05-294Werewolf Therapeutics, Inc. (HOWL)Sale (S): 80,852 @ $0.48 · Sale (S): 27,698 @ $0.46 · Sale (S): 32,556 @ $0.45EDGAR
2026-05-264Werewolf Therapeutics, Inc. (HOWL)Sale (S): 36,387 @ $0.42 · Sale (S): 87,425 @ $0.45 · Sale (S): 67,950 @ $0.47EDGAR
2026-05-204Werewolf Therapeutics, Inc. (HOWL)Sale (S): 22,184 @ $0.50 · Sale (S): 62,970 @ $0.45 · Sale (S): 85,895 @ $0.43EDGAR
2026-05-134Werewolf Therapeutics, Inc. (HOWL)Sale (S): 44,679 @ $0.54EDGAR
2026-05-124Werewolf Therapeutics, Inc. (HOWL)Sale (S): 305,741 @ $0.70 · Sale (S): 33,948 @ $0.67 · Sale (S): 67,885 @ $0.64EDGAR
2026-05-074Werewolf Therapeutics, Inc. (HOWL)Sale (S): 6,860 @ $0.69 · Sale (S): 14,635 @ $0.66 · Sale (S): 79,086 @ $0.63EDGAR
2026-05-044Werewolf Therapeutics, Inc. (HOWL)Sale (S): 168,262 @ $0.72 · Sale (S): 58,394 @ $0.73 · Sale (S): 47,963 @ $0.72EDGAR
2026-04-294Werewolf Therapeutics, Inc. (HOWL)Sale (S): 53,940 @ $0.85 · Sale (S): 95,412 @ $0.73 · Sale (S): 56,559 @ $0.69EDGAR
2026-01-204Werewolf Therapeutics, Inc. (HOWL)Sale (S): 38,782 @ $0.54EDGAR
2026-01-154Werewolf Therapeutics, Inc. (HOWL)Sale (S): 43,198 @ $0.55 · Sale (S): 30,616 @ $0.57 · Sale (S): 37,413 @ $0.55EDGAR
2026-01-144Aktis Oncology, Inc. (AKTS)
jointly with MPM BIOVENTURES 2018, L.P., MPM BIOVENTURES 2018 (B), L.P., MPM BioVentures 2018 LLC, MPM BioVentures 2018 GP LLC, MPM ASSET MANAGEMENT INVESTORS BV2018 LLC, MPM ONCOLOGY INNOVATIONS FUND LP, MPM Oncology Innovations Fund GP LLC
Conversion (C): 1,314,262 · Conversion (C): 5,914,197 · Conversion (C): 1,577,119 · Purchase (P): 1,112,777 @ $18 · Conversion (C): 5,000,000 (derivative) @ $0 · Conversion (C): 22,500,000 (derivative) @ $0 · +1 moreEDGAR
2026-01-124Werewolf Therapeutics, Inc. (HOWL)Sale (S): 7,716 @ $0.63 · Sale (S): 24,678 @ $0.61 · Sale (S): 58,980 @ $0.57EDGAR
2026-01-074Werewolf Therapeutics, Inc. (HOWL)Sale (S): 18,378 @ $0.64 · Sale (S): 40,761 @ $0.65 · Sale (S): 11,915 @ $0.64EDGAR
2026-01-024Werewolf Therapeutics, Inc. (HOWL)Sale (S): 34,847 @ $0.61 · Sale (S): 24,962 @ $0.62 · Sale (S): 18,568 @ $0.63EDGAR
2025-12-294Werewolf Therapeutics, Inc. (HOWL)Sale (S): 59,307 @ $0.69 · Sale (S): 71,428 @ $0.63 · Sale (S): 16,310 @ $0.65 · Sale (S): 35,632 @ $0.63 · Sale (S): 108,606 @ $0.61EDGAR
2025-12-174Werewolf Therapeutics, Inc. (HOWL)Sale (S): 23,640 @ $1.07 · Sale (S): 14,548 @ $1.05 · Sale (S): 9,983 @ $1.14EDGAR
2025-12-124Werewolf Therapeutics, Inc. (HOWL)Sale (S): 37,104 @ $1.06 · Sale (S): 28,009 @ $1.07 · Sale (S): 17,858 @ $1.08EDGAR
2025-12-094Werewolf Therapeutics, Inc. (HOWL)Sale (S): 16,568 @ $0.97 · Sale (S): 34,041 @ $0.99 · Sale (S): 44,570 @ $1.01EDGAR
2025-12-044Werewolf Therapeutics, Inc. (HOWL)Sale (S): 38,043 @ $0.89 · Sale (S): 36,726 @ $0.87 · Sale (S): 53,416 @ $0.97EDGAR
2025-12-014Werewolf Therapeutics, Inc. (HOWL)Sale (S): 38,978 @ $0.98 · Sale (S): 13,014 @ $0.99 · Sale (S): 39,096 @ $0.94EDGAR
2025-11-254Werewolf Therapeutics, Inc. (HOWL)Sale (S): 41,287 @ $0.83 · Sale (S): 56,992 @ $0.98 · Sale (S): 27,297 @ $0.92EDGAR
2025-11-204Werewolf Therapeutics, Inc. (HOWL)Sale (S): 33,776 @ $0.93 · Sale (S): 42,566 @ $0.94 · Sale (S): 26,411 @ $0.89EDGAR
2025-11-174Werewolf Therapeutics, Inc. (HOWL)Sale (S): 58,372 @ $0.98 · Sale (S): 39,560 @ $0.93 · Sale (S): 36,621 @ $0.95EDGAR
2025-11-124Werewolf Therapeutics, Inc. (HOWL)Sale (S): 43,950 @ $1.11 · Sale (S): 31,172 @ $1.18 · Sale (S): 35,818 @ $1.14 · Sale (S): 26,101 @ $1.09EDGAR
2025-11-064Werewolf Therapeutics, Inc. (HOWL)Sale (S): 90,164 @ $1.22 · Sale (S): 30,774 @ $1.22 · Sale (S): 34,947 @ $1.21EDGAR
2025-11-034Werewolf Therapeutics, Inc. (HOWL)Sale (S): 55,795 @ $1.43 · Sale (S): 73,192 @ $1.28 · Sale (S): 60,369 @ $1.29EDGAR
2025-10-294Werewolf Therapeutics, Inc. (HOWL)Sale (S): 46,664 @ $1.72 · Sale (S): 44,327 @ $1.64 · Sale (S): 86,154 @ $1.55EDGAR
2025-06-134Werewolf Therapeutics, Inc. (HOWL)Grant/award (A): 27,000 (derivative) @ $0EDGAR
2025-05-154iTeos Therapeutics, Inc. (ITOS)
jointly with MPM BioVentures 2014, L.P., MPM BioVentures 2014 (B), L.P., MPM Asset Management Investors BV2014 LLC, MPM BioVentures 2014 GP LLC, MPM BioVentures 2014 LLC, MPM BIOVENTURES 2018 (B), L.P., MPM ASSET MANAGEMENT INVESTORS BV2018 LLC, Foley Todd
Sale (S): 630,191 @ $8.06EDGAR
2025-04-304Werewolf Therapeutics, Inc. (HOWL)Option exercise/expiry (X): 28,113 @ $0.09 · Sale (S): 2,425 @ $1.05 · Option exercise/expiry (X): 4,015 (derivative) @ $0 · Option exercise/expiry (X): 24,098 (derivative) @ $0EDGAR
2024-12-124Entrada Therapeutics, Inc. (TRDA)
jointly with MPM BioVentures 2014, L.P., GADICKE ANSBERT, Foley Todd, MPM BioVentures 2014 (B), L.P., MPM Asset Management Investors BV2014 LLC, MPM BioVentures 2014 LLC, MPM BioVentures 2014 GP LLC, MPM BIOVENTURES 2018 (B), L.P., MPM ASSET MANAGEMENT INVESTORS BV2018 LLC
Sale (S): 22,935 @ $20.77 · Sale (S): 21,787 @ $20.23EDGAR
2024-05-244Werewolf Therapeutics, Inc. (HOWL)Grant/award (A): 17,500 (derivative) @ $0EDGAR
2023-06-234Werewolf Therapeutics, Inc. (HOWL)Grant/award (A): 13,200 (derivative) @ $0EDGAR
2023-06-054TCR2 THERAPEUTICS INC. (TCRR)
jointly with MPM BioVentures 2014, L.P., Foley Todd, MPM BioVentures 2014 (B), L.P., MPM Asset Management Investors BV2014 LLC, MPM BioVentures 2014 LLC, MPM BioVentures 2014 GP LLC, MPM ASSET MANAGEMENT LLC
Other (J): 4,158,964 @ $0EDGAR
2023-05-244TCR2 THERAPEUTICS INC. (TCRR)
jointly with MPM ASSET MANAGEMENT LLC
Option exercise/expiry (X): 178,269 @ $0.74 · Sale (S): 70,170 @ $1.88 · Option exercise/expiry (X): 42,761 (derivative) @ $0 · Option exercise/expiry (X): 135,508 (derivative) @ $0EDGAR
2022-06-244Oncorus, Inc. (ONCR)Grant/award (A): 12,500 (derivative) @ $0EDGAR
2022-06-034Werewolf Therapeutics, Inc. (HOWL)Grant/award (A): 11,600 (derivative) @ $0EDGAR
2022-01-064iTeos Therapeutics, Inc. (ITOS)
jointly with MPM BioVentures 2014, L.P., Foley Todd, MPM BioVentures 2014 (B), L.P., MPM Asset Management Investors BV2014 LLC, MPM BioVentures 2014 LLC, MPM BioVentures 2014 GP LLC, MPM BIOVENTURES 2018 (B), L.P., MPM ASSET MANAGEMENT INVESTORS BV2018 LLC
Sale (S): 94,745 @ $42.05 · Sale (S): 19,366 @ $43.20 · Sale (S): 6,768 @ $45.32 · Sale (S): 7,671 @ $46.47 · Sale (S): 18,135 @ $42.03EDGAR
2021-12-074iTeos Therapeutics, Inc. (ITOS)
jointly with MPM BioVentures 2014, L.P., Foley Todd, MPM BioVentures 2014 (B), L.P., MPM Asset Management Investors BV2014 LLC, MPM BioVentures 2014 LLC, MPM BioVentures 2014 GP LLC, MPM BIOVENTURES 2018 (B), L.P., MPM ASSET MANAGEMENT INVESTORS BV2018 LLC
Sale (S): 17,569 @ $34.68 · Sale (S): 2,419 @ $35.44 · Sale (S): 179 @ $36.26 · Sale (S): 8,469 @ $32.35 · Sale (S): 1,171 @ $33.57 · Sale (S): 508 @ $34.08 · +3 moreEDGAR
2021-12-024iTeos Therapeutics, Inc. (ITOS)
jointly with MPM BioVentures 2014, L.P., Foley Todd, MPM BioVentures 2014 (B), L.P., MPM Asset Management Investors BV2014 LLC, MPM BioVentures 2014 LLC, MPM BioVentures 2014 GP LLC, MPM BIOVENTURES 2018 (B), L.P., MPM ASSET MANAGEMENT INVESTORS BV2018 LLC
Sale (S): 5,861 @ $34.62 · Sale (S): 28,076 @ $35.19 · Sale (S): 6,042 @ $33.82 · Sale (S): 5,457 @ $34.61 · Sale (S): 896 @ $35.34 · Sale (S): 29,757 @ $33.74 · +1 moreEDGAR
2021-11-304iTeos Therapeutics, Inc. (ITOS)
jointly with MPM BioVentures 2014, L.P., Foley Todd, MPM BioVentures 2014 (B), L.P., MPM Asset Management Investors BV2014 LLC, MPM BioVentures 2014 LLC, MPM BioVentures 2014 GP LLC, MPM BIOVENTURES 2018 (B), L.P., MPM ASSET MANAGEMENT INVESTORS BV2018 LLC
Sale (S): 6,545 @ $35.49 · Sale (S): 6,129 @ $36.03 · Sale (S): 10,073 @ $34.46 · Sale (S): 298 @ $35.37EDGAR

FilingPulse's Form 4 archive currently extends back to 2020-09-21 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1134657 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs